# Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

> **NCT01405846** · PHASE2 · TERMINATED · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 32 (actual)

## Conditions studied

- Lung Cancer
- Head and Neck Cancer

## Interventions

- **DRUG:** Gefitinib

## Key facts

- **NCT ID:** NCT01405846
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2016-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405846, "Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01405846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*